Xiamen Amoytop Biotech Co (SHSE:688278) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xiamen Amoytop Biotech Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Xiamen Amoytop Biotech Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Xiamen Amoytop Biotech Co's long-term debt to total assets ratio declined from Dec. 2023 (0.00) to Dec. 2024 (0.00). It may suggest that Xiamen Amoytop Biotech Co is progressively becoming less dependent on debt to grow their business.

Xiamen Amoytop Biotech Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Xiamen Amoytop Biotech Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiamen Amoytop Biotech Co LT-Debt-to-Total-Asset Chart

Xiamen Amoytop Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Xiamen Amoytop Biotech Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Xiamen Amoytop Biotech Co LT-Debt-to-Total-Asset Calculation

Xiamen Amoytop Biotech Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	3.268	/	3050.415
	=	0.00

Xiamen Amoytop Biotech Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	3.268	/	3050.415
	=	0.00

Xiamen Amoytop Biotech Co (SHSE:688278) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Xiamen Amoytop Biotech Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Xiamen Amoytop Biotech Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiamen Amoytop Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiamen Amoytop Biotech Co Ltd (SHSE:688278) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.330 Wengjiao Road, Xinyang Industry Zone of Haicang, Fujian, Xiamen, CHN, 361022

Website

http://www.amoytop.com

Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.

Executives

Lan Chun	Director
Wang Jun Ye	Director

Xiamen Amoytop Biotech Co Headlines

No Headlines